Seven-Day Nonbismuth Containing Quadruple Therapy Could Achieve a Grade “A” Success Rate for First-Line Helicobacter pylori Eradication.

This prospective study was to assess the efficacy of nonbismuth containing quadruple therapy as first-line H. pylori treatment and to determine the clinical factors influencing patient outcome. We enrolled 200 H. pylori-infected naïve patients. They were prescribed either a 7-day nonbismuth containi...

Descripción completa

Detalles Bibliográficos

Publicado en:	BioMed Research International Vol. 2015; pp. 1 - 8
Autores principales:	Tai, Wei-Chen, Liang, Chih-Ming, Lee, Chen-Hsiang, Chiu, Chien-Hua, Hu, Ming-Luen, Lu, Lung-Sheng, Kuo, Yuan-Hung, Kuo, Chung-Mou, Yen, Yi-Hao, Kuo, Chung-Huang, Chiou, Shue-Shian, Wu, Keng-Liang, Chiu, Yi-Chun, Hu, Tsung-Hui, Chuah, Seng-Kee
Formato:	research tables/charts Journal Article
Publicado:	Wiley-Blackwell 5/19/2015
Acceso en línea:	Ver este registro en EBSCOhost